IRIDEX Announces Fourth Quarter and Full Year 2014 Conference Call and Release Date
MOUNTAIN VIEW, Calif., Feb. 26, 2015 /PRNewswire/ -- IRIDEX Corporation (NASDAQ: IRIX) today announced that it will release its fourth quarter and full year 2014 financial results after the market closes on Thursday, March 5, 2015. In conjunction with the release, the Company will host a conference call with the investment community at 5:00 p.m. Eastern Time on Thursday, March 5, 2015 to discuss the results of the quarter and other business developments.
Interested parties may access the live conference call via telephone by dialing (877) 407-0784 (US) or (201) 689-8560 (International) and requesting the IRIDEX 2014 Fourth Quarter and Year-End Results Conference Call, or by visiting the Company's website at www.iridex.com. A telephone replay will be available beginning on Thursday, March 5, 2015 through Thursday, March 12, 2015 by dialing (877) 870-5176 (US) or (858) 384-5517 (International) and entering Replay Pin # 13600459.
About IRIDEX
IRIDEX Corporation was founded in 1989 and is a worldwide leader in developing, manufacturing, and marketing innovative and versatile laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology market. We maintain a deep commitment to the success of our customers, with comprehensive technical, clinical, and service support programs. IRIDEX is dedicated to a standard of excellence, offering superior technology for superior results. IRIDEX products are sold in the United States through both direct and independent sales forces and internationally through a combination of a direct sales force and a network of approximately 70 independent distributors into over 100 countries. For further information, visit the Company's website at http://www.iridex.com.
Logo - http://photos.prnewswire.com/prnh/20141001/149809
SOURCE IRIDEX Corporation
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article